Amundi’s Indivior Pharmaceuticals INDV Stock Holding History

Amundi’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Buy	+9,647	New	+$350K	﹤0.01%	1738
2025 Q3	–	Sell	-177,914	Closed	-$2.74M	–	1633
2025 Q2	$2.74M	Buy	177,914 +19,459	+12%	+$227K	﹤0.01%	1024
2025 Q1	$1.49M	Sell	158,455 -15,979	-9%	-$168K	﹤0.01%	1228
2024 Q4	$2.11M	Buy	174,434 +19,010	+12%	+$196K	﹤0.01%	1177
2024 Q3	$1.53M	Sell	155,424 -70,187	-31%	-$822K	﹤0.01%	1204
2024 Q2	$3.44M	Buy	225,611 +22,975	+11%	+$415K	﹤0.01%	1018
2024 Q1	$3.8M	Buy	202,636 +26,015	+15%	+$489K	﹤0.01%	1021
2023 Q4	$2.72M	Buy	176,621 +37,741	+27%	+$670K	﹤0.01%	1115
2023 Q3	$2.69M	Buy	+138,880	New	+$3.17M	﹤0.01%	1105

Other funds holding INDV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi's INDV Position: Q2 2026 in Review

Amundi opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 9,647 shares worth $396K. The stake represents ﹤0.01% of the portfolio and ranks #1738 among its holdings. This is a return to the name: Amundi previously reported a position in INDV as recently as Q2 2025.

Amundi first reported a position in INDV in Q3 2023 and has held it in 9 quarters since. The position peaked at $3.8M in Q1 2024. 339 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

Amundi held 9,647 shares of Indivior Pharmaceuticals worth $396K as of Q2 2026.
Indivior Pharmaceuticals was a new Amundi position in Q2 2026.
Indivior Pharmaceuticals made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1738 holding.
Amundi first reported a position in Indivior Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
Amundi's Indivior Pharmaceuticals position peaked at $3.8M in Q1 2024.
339 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.